Marina Ziche

Title: Marina Ziche: Innovator in Angiogenesis Research

Introduction

Marina Ziche is a prominent inventor based in Florence, Italy. She has made significant contributions to the field of angiogenesis research, focusing on the development of innovative compounds that promote and inhibit blood vessel formation. With a total of 3 patents, her work has implications for treating various angiogenesis-dependent conditions.

Latest Patents

One of her latest patents involves the use of Compound B as an angiogenic agent in combination with human growth factors. This compound has been shown to promote angiogenesis, specifically the budding of capillaries. The combination of Compound B with human growth factors, such as bFGF, demonstrates synergistic angiogenetic effects. Another notable patent features polypeptides derived from endostatin that exhibit antiangiogenic activity. These polypeptides, which correspond to the sequence of endostatin, have inhibitory effects on angiogenesis and are useful in treating angiogenesis-dependent tumors.

Career Highlights

Throughout her career, Marina Ziche has worked with various esteemed organizations. She has been associated with Applied Research Systems Ars Holding N.V. and Università Degli Studi di Milano. Her research has significantly advanced the understanding of angiogenesis and its applications in medicine.

Collaborations

Marina has collaborated with notable colleagues, including Silvia Donini and Francesco Chillemi. Their joint efforts have contributed to the success of her research and the development of her patented innovations.

Conclusion

Marina Ziche's work in angiogenesis research highlights her innovative spirit and dedication to advancing medical science. Her patents and collaborations reflect her commitment to finding solutions for complex health issues.